Invesaro

Stocks Health care BHC

NYSE · Health care

Bausch Health Companies Inc. (BHC)

Bausch Health Companies Inc. brought in $10.9B of revenue over the twelve months to June 30, 2026, up 10.1% from a year earlier. It posted a net loss of $1.1B. Operating cash flow minus capital spending left $1B of free cash flow in fiscal 2025. At June 30, 2026 it held $1.8B in cash against $20.7B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 30, 2026.

Revenue (last 12 months)
$10.9B
+10.1% year on year
Net margin
-10.1%

What Bausch Health Companies Inc. does

Bausch Health Companies Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker BHC.

Revenue and profit by year

Revenue
FY18: $8.4B $8.4B FY18FY19: $8.6B $8.6B FY19FY20: $8B $8B FY20FY21: $8.4B $8.4B FY21FY22: $8.1B $8.1B FY22FY23: $8.8B $8.8B FY23FY24: $9.6B $9.6B FY24FY25: $10.3B $10.3B FY25
Net income
FY18: -$4.1B -$4.1B FY18FY19: -$1.8B -$1.8B FY19FY20: -$560M -$560M FY20FY21: -$948M -$948M FY21FY22: -$225M -$225M FY22FY23: -$592M -$592M FY23FY24: -$46M -$46M FY24FY25: $157M $157M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$10.3B$1.8B$157M$0.42$1B
2024$9.6B$1.5B-$46M-$0.13$1.3B
2023$8.8B$963M-$592M-$1.62$817M
2022$8.1B$454M-$225M-$0.62-$946M
2021$8.4B$450M-$948M-$2.64$1.2B
2020$8B$676M-$560M-$1.58$809M

Latest SEC filings

What Bausch Health Companies Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. July 30, 2026
    Quarterly report 10-Q · period to June 30, 2026
  2. July 29, 2026
  3. July 1, 2026
  4. June 1, 2026
  5. May 19, 2026
  6. April 30, 2026
    Quarterly report 10-Q · period to March 31, 2026
  7. April 29, 2026
  8. April 8, 2026
  9. April 8, 2026
  10. April 8, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 20, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about BHC

What does Bausch Health Companies Inc. do?

Bausch Health Companies Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker BHC.

Is Bausch Health Companies Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $1.1B on revenue of $10.9B.

How much revenue does Bausch Health Companies Inc. make?

Over the twelve months to June 30, 2026 Bausch Health Companies Inc. reported revenue of $10.9B. That is 10.1% more than a year earlier.

When did Bausch Health Companies Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 30, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from August 20, 2026.

Similar companies

Follow BHC

Get an email when Bausch Health Companies Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow BHC: get an email when it files

Where the numbers come from

Financial figures are the values Bausch Health Companies Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.